Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.
about
Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapyPostoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer.Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
P2860
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular biomarkers in extrah ...... esidual disease after surgery.
@ast
Molecular biomarkers in extrah ...... esidual disease after surgery.
@en
type
label
Molecular biomarkers in extrah ...... esidual disease after surgery.
@ast
Molecular biomarkers in extrah ...... esidual disease after surgery.
@en
prefLabel
Molecular biomarkers in extrah ...... esidual disease after surgery.
@ast
Molecular biomarkers in extrah ...... esidual disease after surgery.
@en
P2093
P2860
P1476
Molecular biomarkers in extrah ...... residual disease after surgery
@en
P2093
Hae Jin Park
Hye Sook Min
Hyeon Kang Koh
P2860
P304
P356
10.3857/ROJ.2012.30.4.197
P50
P577
2012-12-31T00:00:00Z